NFormyl Peptide Receptor 2 Pipeline Review, H1 Developing Markets Expected to Lead Future Demand Growth 2016 "The Report NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Pipeline Review, H1 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. MarketResearchReports.biz" Global Markets Directs, NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLP RI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Pipeline Review, H1 2016, provides in depth analysis on NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted pipeline therapeutics. The report provides comprehensive information on the NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics development and features dormant and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/735288 Scope The report provides a snapshot of the global therapeutic landscape for NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) The report reviews NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics and enlists all their major and minor projects The report assesses NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type The report summarizes all the dormant and discontinued pipeline projects The report reviews latest news and deals related to NFormyl Peptide Receptor 2 (FMLP Related Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics Reasons to buy Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Identify and understand the targeted therapy areas and indications for NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Identify the use of drugs for target identification and drug repurposing Identify potential new clients or partners in the target demographic Develop strategic initiatives by understanding the focus areas of leading companies Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) development landscape Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Overview 6 Therapeutics Development 7 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Products under Development by Stage of Development 7 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Products under Development by Therapy Area 8 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Products under Development by Indication 9 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Pipeline Products Glance 10 Early Stage Products 10 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Products under Development by Companies 11 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Products under Development by Universities/Institutes 13 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Therapeutics Assessment 15 Assessment by Monotherapy/Combination Products 15 Assessment by Mechanism of Action 16 Assessment by Molecule Type 18 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Companies Involved in Therapeutics Development 20 BristolMyers Squibb Company 20 CohBar, Inc. 21 Polyphor Ltd. 22 NFormyl Peptide Receptor 2 (FMLPRelated Receptor I or FMLPRI or Formyl Peptide ReceptorLike 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Drug Profiles 23 Drugs to Agonize FPR2 for Inflammation Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 Humanin Drug Profile 24 Product Description 24 Mechanism Of Action 24
R&D Progress 24 NCP70X Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 About us MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. Contact Mr. Nachiket State Tower 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +15186212074 Website: http://www.marketresearchreports.biz/ E: sales@marketresearchreports.biz